You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
3 April 2023
Harbour BioMed Reports Full Year 2022 Financial Results
14 February 2023
Cullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed
25 March 2022
Harbour BioMed Reports Full Year 2021 Financial Results: Empower Value Creation with Global Innovation Capabilities